To hear about similar clinical trials, please enter your email below
Trial Title:
The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
NCT ID:
NCT00257179
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
Tissue factor
Lung cancer
Tissue factor protein inhibitor
Factor VII
Factor X
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Other
Summary:
This study uses serum tissue factor and tissue factor inhibitor and factor VII to monitor
the pre-coagulation status in lung cancer patients and to correlate the pre-coagulation
status with clinical staging and prognosis.
Detailed description:
The staging of lung cancer was according to tumor size, involvement of lymph node and
metastatic status. But there is a different prognosis in cancer patients of the same
stage. The coagulation status of cancer patients was considered as an important possible
prognostic factor. So in this study, we want to evaluate patients' coagulation status and
find the relation of coagulation status and cancer status.
We thus propose a prospective study using coagulation factors in order to search for the
relationship between cancer stage and pre-coagulation status in Taiwanese lung cancer
patients. We will also evaluate the potential use of tissue factor as a prognosis
predictor in lung cancer patients.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients with newly-diagnosed lung cancer
- Serum from cancer-free healthy volunteers
Exclusion Criteria:
- Chronic renal failure or end-stage renal disease [ESRD] (creatinine [Cr] > 2 )
- Hyperlipidemia on statin therapy
- Acute myocardial infarction
- Tapal or Plavix use
- Active thromboembolic event
- Severe liver disease (> child B)
Gender:
All
Minimum age:
16 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
National Taiwan University Hospital
Address:
City:
Taipei
Country:
Taiwan
Status:
Recruiting
Contact:
Last name:
Chong-Jen Yu, M.D., Ph.D.
Phone:
886-2-2356-2905
Start date:
June 2005
Lead sponsor:
Agency:
National Taiwan University Hospital
Agency class:
Other
Source:
National Taiwan University Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00257179
